{"result": "(\"entity\"<|>NADYA<|>ORGANIZATION<|>NADYA is a group focused on home and outpatient artificial nutrition, studying complications related to enteral nutrition.)\n##\n(\"entity\"<|>MISOPROSTOL<|>ORGANIZATION<|>Misoprostol is a drug used for patients with functional defecation disorders, acting as a prostaglandin analog.)\n##\n(\"entity\"<|>COLCHICINE<|>ORGANIZATION<|>Colchicine is a medication used in the treatment of certain gastrointestinal conditions.)\n##\n(\"entity\"<|>LUBIPROSTONE<|>ORGANIZATION<|>Lubiprostone is a local activator of chloride channels used for treating constipation.)\n##\n(\"entity\"<|>TOXINA BOTULÍNICA<|>ORGANIZATION<|>Botulinum toxin is used in specific cases for treating functional defecation disorders.)\n##\n(\"entity\"<|>FIBRA<|>ORGANIZATION<|>Fiber is a dietary component recommended for improving bowel regularity and reducing the need for laxatives.)\n##\n(\"entity\"<|>ESTREÑIMIENTO<|>EVENT<|>Constipation is a common gastrointestinal complication, particularly in patients receiving enteral nutrition.)\n##\n(\"entity\"<|>FLORA BACTERIANA<|>ORGANIZATION<|>The intestinal flora is a unique collection of bacteria in each individual, crucial for health and immune function.)\n##\n(\"entity\"<|>MICROBIOMA INTESTINAL<|>ORGANIZATION<|>The intestinal microbiome refers to the genetic makeup of the bacteria in the gut, important for understanding gut health.)\n##\n(\"relationship\"<|>NADYA<|>ESTREÑIMIENTO<|>NADYA studies complications related to enteral nutrition, including constipation, which is a frequent issue in their research<|>7)\n##\n(\"relationship\"<|>MISOPROSTOL<|>ESTREÑIMIENTO<|>Misoprostol is used to treat patients with functional defecation disorders, which can include constipation<|>6)\n##\n(\"relationship\"<|>COLCHICINE<|>ESTREÑIMIENTO<|>Colchicine is utilized in treating gastrointestinal conditions that may involve constipation<|>6)\n##\n(\"relationship\"<|>LUBIPROSTONE<|>ESTREÑIMIENTO<|>Lubiprostone is prescribed for patients suffering from constipation<|>6)\n##\n(\"relationship\"<|>TOXINA BOTULÍNICA<|>ESTREÑIMIENTO<|>Botulinum toxin is used in specific cases to address functional defecation disorders, which can lead to constipation<|>6)\n##\n(\"relationship\"<|>FIBRA<|>ESTREÑIMIENTO<|>Fiber is recommended to alleviate constipation, especially in patients on enteral nutrition<|>8)\n##\n(\"relationship\"<|>FLORA BACTERIANA<|>MICROBIOMA INTESTINAL<|>The intestinal flora contributes to the microbiome, influencing gut health and function<|>9)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ajes terapéuticos como son la utilización de laxantes, fibra o placebo. Según este estudio, los laxantes aumentaban el bolo fecal, disminuían el dolor abdominal y mejoraban la consistencia de las heces con respecto al placebo y no se observaron efectos secundarios severos con ninguno de los tratamientos. El estudio concluye que no hay suficiente evidencia para recomendar un tratamiento u otro32. La fibra puede agravar los síntomas de pacientes con estreñimiento cuando el tránsito es extremadamente lento o en aquellos con afectación de la médula espinal, por ello se recomienda en general abordar el estreñimiento comenzando con dosis bajas de fibra e ir incrementando según tolerancia y, solo en el caso de no mejorar, comenzar con laxantes. Existe un pequeño estudio en el cual se compara el efecto de las ciruelas pasas con el plantago; en dicho estudio, los pacientes refirieron un número mayor de movimientos espontáneos con las pasas que con el plantago, igualmente también reportaron una mejora en la consistencia de las heces; ambos tratamientos fueron bien tolerados33.\n\nLaxantes. Disponemos en la actualidad de distintos tipos de laxantes dependiendo de su composición y mecanismo de acción. Así, los más utilizados son:\n\n- Laxantes osmóticos o salinos (sulfato de magnesio, sulfato de sodio): preparados hipertónicos que aumentan la presión osmótica en la luz intestinal, aumentando la excreción de agua.\n- Laxantes estimulantes (bisacodilo, sen, aceite de ricino): alteran la absorción de agua y electrolitos, aumentando el contenido de los mismos en la luz intestinal y en el bolo fecal. Además, estimulan el peristaltismo por acción sobre las terminaciones nerviosas del intestino.\n- Laxantes emolientes (docusato sódico, parafina): permiten la mezcla de micropartículas de agua con lípidos del bolo fecal ablandando su consistencia.\n- Laxantes que aumentan el bolo intestinal (metilcelulosa, plantago ovata, salvado de trigo): son coloides hidrófilos que aumentan su volumen absorbiendo agua.\n\nOtros fármacos. Se han utilizado algunos fármacos en aquellos pacientes en los que, más que un enlentecimiento del tránsito, existe una alteración funcional de la defecación como son el misoprostol (análogo de las prostaglandinas), la colchicina, el lubiprostone (activador local de los canales cloruro) o la toxina botulínica34.\n\nTratamiento quirúrgico. Solo en situaciones límite y en pacientes muy seleccionados, en ocasiones se ha optado por un tratamiento quirúrgico mediante una colectomía subtotal.\n\nEstreñimiento asociado a nutrición enteral. Según un estudio multicéntrico y prospectivo del grupo NADYA (Nutrición Artificial Domiciliaria Y Ambulatoria) sobre complicaciones de la nutrición enteral domiciliaria, aproximadamente el 50% presentan complicaciones gastrointestinales, siendo el estreñimiento la más frecuente (25%). El mantenimiento de un ritmo intestinal regular es uno de los objetivos para añadir fibra a la nutrición enteral, sobre todo en aquellos pacientes que la requieren durante largo tiempo. La nutrición enteral con fibra disminuye el uso de laxantes y aumenta el peso y la frecuencia de las deposiciones. Su utilidad está demostrada en cuadros de estreñimiento de duración mayor a 2 semanas y utilizando tanto polisacáridos de soja como distintas combinaciones de fibras35.\n\n## 5. Conclusiones\n\nEl intestino es el mayor órgano de intercambio y comunicación entre el medio externo y el medio interno, esto le confiere un papel único en la fisiología humana, pues la obtención de un equilibrio saludable entre intestino y la flora bacteriana en relación de simbiosis es de crucial importancia en la salud del individuo. El proceso hasta adquirir este equilibrio y un desarrollo óptimo del sistema inmune se inicia ya en la vida intrauterina, posteriormente será a través del canal del parto y en la primera infancia cuando se alcanza el mayor nivel de desarrollo de este complejo proceso biológico de convivencia. Esta relación es la que determinará el óptimo funcionamiento intestinal no solo en la absorción de nutrientes, sino en su papel metabólico e inmune.\n\nLa flora bacteriana existente en el intestino es propia de cada individuo. El estudio de la misma ha estado muy limitado debido a que la mayoría de las bacterias intestinales no pueden ser aisladas en medios de cultivos habituales. A día de hoy, las nuevas técnicas de determinación genética hacen posible conocer mejor y más rápidamente el microbioma intestinal humano. Este avance supone un importante paso en el desarrollo científico de este campo de investigación.\n\nEl fallo en la adquisición inicial de este equilibrio o la alteración del mismo una vez\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}